Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
On August 14, 2023, the FDA granted accelerated approval for elranatamab-bcmm. This approval is specifically for adults with relapsed or refractory multiple myeloma who have undergone at least four prior lines of therapy. These therapies must include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. It is important to note that this a…